{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["N-acetylcysteine", "antioxidant and anti-inflammatory compounds", "inflammation", "ischemic stroke", "oxidative stress"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32547030", "DateRevised": {"Year": "2022", "Month": "04", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10.2147/NDT.S241497"], "Journal": {"ISSN": "1176-6328", "JournalIssue": {"Volume": "16", "PubDate": {"Year": "2020"}}, "Title": "Neuropsychiatric disease and treatment", "ISOAbbreviation": "Neuropsychiatr Dis Treat"}, "ArticleTitle": "Evidence for a Beneficial Effect of Oral N-acetylcysteine on Functional Outcomes and Inflammatory Biomarkers in Patients with Acute Ischemic Stroke.", "Pagination": {"StartPage": "1265", "EndPage": "1278", "MedlinePgn": "1265-1278"}, "Abstract": {"AbstractText": ["Numerous preclinical studies have demonstrated the potential neuroprotective effects of N-acetylcysteine (NAC) in the treatment of brain ischemia. Accordingly, the present study aimed to assess the potential therapeutic effects of oral NAC in patients with acute ischemic stroke.", "In a randomized, double-blind, placebo-controlled trial study, 68 patients with acute ischemic stroke with the onset of symptoms less than 24 hours were randomly assigned to either the NAC-treated group or placebo-treated group. NAC and matched placebo were administrated by a 72-hour oral protocol (initially 4 grams loading dose and after on, 4 g in 4 equal divided doses for more 2 days). The primary outcomes were quantification of any neurologic deficit by the use of the National Institute of Health Stroke Scale (NIHSS) score and functional disability by the use of the modified Rankin scale (mRS) at 90 days after stroke. Additionally, serum levels of markers of oxidative stress and inflammation as a main mechanism of its action were assessed at baseline and the end of 3-day treatment protocol.", "NAC-treated patients in comparison with placebo-treated patients showed a significantly lower mean NIHSS scores at day 90 after stroke. A favorable functional outcome which was defined as an mRS score of 0 or 1, also in favor of NAC compared to placebo was noted on day 90 after stroke (57.6% in the NAC-treated group compared with 28.6% in the placebo-treated group). Further, compared to the placebo, NAC treatment significantly decreased serum levels of proinflammatory biomarkers such as interleukin 6 (IL-6), soluble intercellular cell adhesion molecule-1 (sICAM-1), \ufeffnitric oxide (NO), \ufeffmalondialdehyde (MDA), and neuron-specific enolase (NSE) and significantly increased serum levels of anti-oxidant biomarkers such as superoxide dismutase (SOD), glutathione peroxidase (GPx), and total thiol groups (TTG).", "The pattern of results suggests that oral NAC administration early after an acute ischemic stroke is associated with a better outcome profile in terms of acute neurological deficit and disability grade compared to placebo. NAC may improve neurological outcomes of patients with stroke at least in part by its antioxidant and anti-inflammatory effects."], "CopyrightInformation": "\u00a9 2020 Sabetghadam et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Sabetghadam", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Mazdeh", "ForeName": "Mehrdokht", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Abolfathi", "ForeName": "Parnaz", "Initials": "P"}, {"Identifier": ["0000-0001-7521-4909"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Modeling of Noncommunicable Diseases Research Center, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Mohammadi", "ForeName": "Younes", "Initials": "Y"}, {"Identifier": ["0000-0003-4119-1600"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Mehrpooya", "ForeName": "Maryam", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Neuropsychiatr Dis Treat", "NlmUniqueID": "101240304", "ISSNLinking": "1176-6328"}, "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Zandieh A, Kahaki ZZ, Sadeghian H, et al. A simple risk score for early ischemic stroke mortality derived from National Institutes of Health Stroke Scale: a discriminant analysis. Clin Neurol Neurosurg. 2013;115(7):1036\u20131039. doi:10.1016/j.clineuro.2012.10.034", "ArticleIdList": ["10.1016/j.clineuro.2012.10.034", "23219218"]}, {"Citation": "Caplan LR, Hon FK. Clinical diagnosis of patients with cerebrovascular disease. Prim Care. 2004;31(1):95\u2013109. doi:10.1016/S0095-4543(03)00118-0", "ArticleIdList": ["10.1016/S0095-4543(03)00118-0", "15110161"]}, {"Citation": "Caplan L. basic pathology, anatomy, and pathophysiology of stroke. Caplan stroke. 2009:22\u201363."}, {"Citation": "Kunz A, Iadecola C. Cerebral vascular dysregulation in the ischemic brain. Handb Clin Neurol. 2009;92:283\u2013305.", "ArticleIdList": ["PMC3982865", "18790280"]}, {"Citation": "Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology. 2010;17(3):197\u2013218. doi:10.1016/j.pathophys.2009.12.001", "ArticleIdList": ["10.1016/j.pathophys.2009.12.001", "20074922"]}, {"Citation": "Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391\u2013397. doi:10.1016/S0166-2236(99)01401-0", "ArticleIdList": ["10.1016/S0166-2236(99)01401-0", "10441299"]}, {"Citation": "Bansal S, Sangha KS, Khatri P. Drug treatment of acute ischemic stroke. Am J Cardiovasc Drugs. 2013;13(1):57\u201369. doi:10.1007/s40256-013-0007-6", "ArticleIdList": ["10.1007/s40256-013-0007-6", "PMC3840541", "23381911"]}, {"Citation": "Manzanero S, Santro T, Arumugam TV. Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int. 2013;62(5):712\u2013718. doi:10.1016/j.neuint.2012.11.009", "ArticleIdList": ["10.1016/j.neuint.2012.11.009", "23201332"]}, {"Citation": "Hepel M, Andreescu S. Oxidative Stress and Human Health Oxidative Stress: Diagnostics, Prevention, and Therapy Volume 2. ACS Symposium Series. 1200:American Chemical Society; 2015. p.1\u201333. doi:10.1021/bk-2015-1200.ch001", "ArticleIdList": ["10.1021/bk-2015-1200.ch001"]}, {"Citation": "Chan PH. Role of oxidants in ischemic brain damage. Stroke. 1996;27(6):1124\u20131129. doi:10.1161/01.STR.27.6.1124", "ArticleIdList": ["10.1161/01.STR.27.6.1124", "8650725"]}, {"Citation": "Chang CY, Lai YC, Cheng TJ, Lau MT, Hu ML. Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radic Res. 1998;28(1):15\u201324. doi:10.3109/10715769809097872", "ArticleIdList": ["10.3109/10715769809097872", "9554829"]}, {"Citation": "Cherubini A, Polidori Maria C, Bregnocchi M, et al. Antioxidant profile and early outcome in stroke patients. Stroke. 2000;31(10):2295\u20132300. doi:10.1161/01.STR.31.10.2295", "ArticleIdList": ["10.1161/01.STR.31.10.2295", "11022053"]}, {"Citation": "Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic Res. 2002;36(3):265\u2013268. doi:10.1080/10715760290019273", "ArticleIdList": ["10.1080/10715760290019273", "12071344"]}, {"Citation": "Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S. Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry. 2003;74(3):312. doi:10.1136/jnnp.74.3.312", "ArticleIdList": ["10.1136/jnnp.74.3.312", "PMC1738343", "12588914"]}, {"Citation": "Liu H, Uno M, Kitazato KT, et al. Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction. Brain Res. 2004;1025(1\u20132):43\u201350. doi:10.1016/j.brainres.2004.07.071", "ArticleIdList": ["10.1016/j.brainres.2004.07.071", "15464743"]}, {"Citation": "De Keyser J, De Klippel N, Merkx H, Vervaeck M, Herroelen L. Serum concentrations of vitamins A and E and early outcome after ischaemic stroke. Lancet. 1992;339(8809):1562\u20131565. doi:10.1016/0140-6736(92)91830-2", "ArticleIdList": ["10.1016/0140-6736(92)91830-2", "1351549"]}, {"Citation": "Spranger M, Krempien S, Schwab S, Donneberg S, Hacke W. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Stroke. 1997;28(12):2425\u20132428.", "ArticleIdList": ["9412626"]}, {"Citation": "Gariballa SE, Hutchin TP, Sinclair AJ. Antioxidant capacity after acute ischaemic stroke. QJM. 2002;95(10):685\u2013690. doi:10.1093/qjmed/95.10.685", "ArticleIdList": ["10.1093/qjmed/95.10.685", "12324641"]}, {"Citation": "Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796\u2013808. doi:10.1038/nm.2399", "ArticleIdList": ["10.1038/nm.2399", "PMC3137275", "21738161"]}, {"Citation": "Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol. 2003;62(2):127\u2013136. doi:10.1093/jnen/62.2.127", "ArticleIdList": ["10.1093/jnen/62.2.127", "12578222"]}, {"Citation": "Jin R, Liu L, Zhang S, Nanda A, Li G. Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res. 2013;6(5):834\u2013851. doi:10.1007/s12265-013-9508-6", "ArticleIdList": ["10.1007/s12265-013-9508-6", "PMC3829610", "24006091"]}, {"Citation": "Smith CJ, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;4:2. doi:10.1186/1471-2377-4-2", "ArticleIdList": ["10.1186/1471-2377-4-2", "PMC331413", "14725719"]}, {"Citation": "Intiso D, Zarrelli MM, Lagioia G, et al. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci. 2004;24(6):390\u2013396. doi:10.1007/s10072-003-0194-z", "ArticleIdList": ["10.1007/s10072-003-0194-z", "14767684"]}, {"Citation": "Pei Y, Liu H, Yang Y, Yang Y, Jiao Y. Biological activities and potential oral applications of n-acetylcysteine: progress and prospects. Stroke. 2018;2018:2835787.", "ArticleIdList": ["PMC5937417", "29849877"]}, {"Citation": "Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest. 2001;107(2):135\u2013142. doi:10.1172/JCI11914", "ArticleIdList": ["10.1172/JCI11914", "PMC199180", "11160126"]}, {"Citation": "Zhang Q, Ju Y, Ma Y, Wang T. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: a randomized controlled trial. Medicine (Baltimore). 2018;97(45):e13087. doi:10.1097/MD.0000000000013087", "ArticleIdList": ["10.1097/MD.0000000000013087", "PMC6250560", "30407312"]}, {"Citation": "Hashemi G, Mirjalili M, Basiri Z, et al. A pilot study to evaluate the effects of oral N-Acetyl cysteine on inflammatory and oxidative stress biomarkers in rheumatoid arthritis. Curr Rheumatol Rev. 2019;15(3):246\u2013253. doi:10.2174/1573403X14666180926100811", "ArticleIdList": ["10.2174/1573403X14666180926100811", "30255760"]}, {"Citation": "Kilciksiz S, Demirel C, Erdal N, et al. The effect of N-acetylcysteine on biomarkers for radiation-induced oxidative damage in a rat model. Acta Med Okayama. 2008;62(6):403\u2013409. doi:10.18926/AMO/30946", "ArticleIdList": ["10.18926/AMO/30946", "19122686"]}, {"Citation": "Sandhir R, Sood A, Mehrotra A, Kamboj SS. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease. Neurodegener Dis. 2012;9(3):145\u2013157. doi:10.1159/000334273", "ArticleIdList": ["10.1159/000334273", "22327485"]}, {"Citation": "Tchantchou F, Graves M, Rogers E, Ortiz D, Shea TB. N-acetyl cysteine alleviates oxidative damage to central nervous system of ApoE-deficient mice following folate and vitamin E-deficiency. J Alzheimers Dis. 2005;7(2):135\u2013138;discussion 173\u2013180. doi:10.3233/JAD-2005-7206", "ArticleIdList": ["10.3233/JAD-2005-7206", "15851851"]}, {"Citation": "Pan J, Xiao Q, Sheng CY, et al. Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson\u2019s disease. Neurochem Int. 2009;54(7):418\u2013425. doi:10.1016/j.neuint.2009.01.013", "ArticleIdList": ["10.1016/j.neuint.2009.01.013", "19428783"]}, {"Citation": "Wang B, Yee AT, Stokes KY. N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes. Redox Biol. 2018;14:218\u2013228. doi:10.1016/j.redox.2017.09.005", "ArticleIdList": ["10.1016/j.redox.2017.09.005", "PMC5619994", "28961512"]}, {"Citation": "Cuzzocrea S, Mazzon E, Costantino G, et al. Beneficial effects of n-acetylcysteine on ischaemic brain injury. Br J Pharmacol. 2000;130(6):1219\u20131226. doi:10.1038/sj.bjp.0703421", "ArticleIdList": ["10.1038/sj.bjp.0703421", "PMC1572181", "10903958"]}, {"Citation": "Powers William J, Rabinstein Alejandro A, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 guidelines for the early management of acute ischemic stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344\u2013e418. doi:10.1161/STR.0000000000000211", "ArticleIdList": ["10.1161/STR.0000000000000211", "31662037"]}, {"Citation": "Hoffer M, Balaban CD, Slade M, Tsao J, Hoffer B. Amelioration of acute sequelae of blast induced mild traumatic brain injury by n-acetyl cysteine: a double-blind, placebo controlled study. PLoS One. 2013;8:e54163. doi:10.1371/journal.pone.0054163", "ArticleIdList": ["10.1371/journal.pone.0054163", "PMC3553161", "23372680"]}, {"Citation": "Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav. 2014;4(2):108\u2013122. doi:10.1002/brb3.208", "ArticleIdList": ["10.1002/brb3.208", "PMC3967529", "24683506"]}, {"Citation": "Perera M, Ma H, Arakawa S, et al. Inflammation following stroke. J Clin Neurosci. 2006;13:1\u20138. doi:10.1016/j.jocn.2005.07.005", "ArticleIdList": ["10.1016/j.jocn.2005.07.005", "16410192"]}, {"Citation": "Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996;27(10):1817\u20131820. doi:10.1161/01.STR.27.10.1817", "ArticleIdList": ["10.1161/01.STR.27.10.1817", "8841337"]}, {"Citation": "van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604\u2013607. doi:10.1161/01.STR.19.5.604", "ArticleIdList": ["10.1161/01.STR.19.5.604", "3363593"]}, {"Citation": "Benzie IF, Szeto YT. Total antioxidant capacity of teas by the ferric reducing/antioxidant power assay. J Agric Food Chem. 1999;47(2):633\u2013636. doi:10.1021/jf9807768", "ArticleIdList": ["10.1021/jf9807768", "10563944"]}, {"Citation": "Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70\u201377. doi:10.1016/0003-9861(59)90090-6", "ArticleIdList": ["10.1016/0003-9861(59)90090-6", "13650640"]}, {"Citation": "Botsoglou NA, Fletouris DJ, Papageorgiou GE, Vassilopoulos VN, Mantis AJ, Trakatellis AG. Rapid, sensitive, and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food, and feedstuff samples. J Agric Food Chem. 1994;42(9):1931\u20131937. doi:10.1021/jf00045a019", "ArticleIdList": ["10.1021/jf00045a019"]}, {"Citation": "Unnebrink K, Windeler J. Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Stat Med. 2001;20(24):3931\u20133946. doi:10.1002/sim.1149", "ArticleIdList": ["10.1002/sim.1149", "11782044"]}, {"Citation": "Li B-H, Ding X, Yin Y-W, et al. Meta-analysis of clinical outcomes of intravenous recombinant tissue plasminogen activator for acute ischemic stroke: within 3 hours versus 3\u20134.5 hours. Curr Med Res Opin. 2013;29(9):1105\u20131114. doi:10.1185/03007995.2013.818533", "ArticleIdList": ["10.1185/03007995.2013.818533", "23790245"]}, {"Citation": "Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42(7):1952\u20131955. doi:10.1161/STROKEAHA.110.612358", "ArticleIdList": ["10.1161/STROKEAHA.110.612358", "PMC4114342", "21636813"]}, {"Citation": "Khan M, Sekhon B, Jatana M, et al. Administration of N\u2010acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res. 2004;76(4):519\u2013527. doi:10.1002/jnr.20087", "ArticleIdList": ["10.1002/jnr.20087", "15114624"]}, {"Citation": "Danduga RCSR, Reddy DS, Seshadri SM, Has KSS, Kumar KP. Effect of combination therapy with pramipexole and n-acetylcysteine on global cerebral ischemic reperfusion injury in rats. Iran J Basic Med Sci. 2018;21(6):569.", "ArticleIdList": ["PMC6015253", "29942446"]}, {"Citation": "Sekhon B, Sekhon C, Khan M, et al. N\u2010acetyl cysteine protects against injury in animal model of transient focal cerebral ischemia. J Neurochem. 2002;81:101\u2013105. doi:10.1046/j.1471-4159.81.s1.40_12.x", "ArticleIdList": ["10.1046/j.1471-4159.81.s1.40_12.x"]}, {"Citation": "Krzy\u017canowska W, Pomierny B, Bystrowska B, et al. Ceftriaxone-and N-acetylcysteine-induced brain tolerance to ischemia: influence on glutamate levels in focal cerebral ischemia. PLoS One. 2017;12:10. doi:10.1371/journal.pone.0186243", "ArticleIdList": ["10.1371/journal.pone.0186243", "PMC5646803", "29045497"]}, {"Citation": "Rodrigo R, Fern\u00e1ndez-Gajardo R, Guti\u00e9rrez R, et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013;12(5):698\u2013714.", "ArticleIdList": ["23469845"]}, {"Citation": "Aldini G, Altomare A, Baron G, et al. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res. 2018;52(7):751\u2013762. doi:10.1080/10715762.2018.1468564", "ArticleIdList": ["10.1080/10715762.2018.1468564", "29742938"]}, {"Citation": "Ribeiro G, Roehrs M, Bairros A, et al. N-acetylcysteine on oxidative damage in diabetic rats. Drug Chem Toxicol. 2011;34(4):467\u2013474. doi:10.3109/01480545.2011.564179", "ArticleIdList": ["10.3109/01480545.2011.564179", "21770721"]}, {"Citation": "Yesilbursa D, Serdar A, Senturk T, Serdar Z, Sa\u011f S, Cordan J. Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction. Heart Vessels. 2006;21(1):33\u201337. doi:10.1007/s00380-005-0854-4", "ArticleIdList": ["10.1007/s00380-005-0854-4", "16440146"]}, {"Citation": "Huang Q, Aluise CD, Joshi G, et al. Potential in vivo amelioration by N\u2010acetyl\u2010L\u2010cysteine of oxidative stress in brain in human double mutant APP/PS\u20101 knock\u2010in mice: toward therapeutic modulation of mild cognitive impairment. J Neurosci Res. 2010;88(12):2618\u20132629. doi:10.1002/jnr.22422", "ArticleIdList": ["10.1002/jnr.22422", "20648652"]}, {"Citation": "Yin J, Ren W, Yang G, et al. l-Cysteine metabolism and its nutritional implications. Mol Nutr Food Res. 2016;60(1):134\u2013146. doi:10.1002/mnfr.201500031", "ArticleIdList": ["10.1002/mnfr.201500031", "25929483"]}, {"Citation": "Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol. 2008;28(3):s11\u2013s16. doi:10.1161/ATVBAHA.107.159178", "ArticleIdList": ["10.1161/ATVBAHA.107.159178", "18174453"]}, {"Citation": "Chrissobolis S, Miller AA, Drummond GR, Kemp-Harper BK, Sobey CG. Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci (Landmark Ed). 2011;16:1733\u20131745. doi:10.2741/3816", "ArticleIdList": ["10.2741/3816", "21196259"]}, {"Citation": "Gibson KR, Winterburn TJ, Barrett F, Sharma S, MacRury SM, Megson IL. Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes. Cardiovasc Diabetol. 2011;10(1):43. doi:10.1186/1475-2840-10-43", "ArticleIdList": ["10.1186/1475-2840-10-43", "PMC3120650", "21600014"]}, {"Citation": "Treweeke A, Winterburn T, Mackenzie I, et al. N-Acetylcysteine inhibits platelet\u2013monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial. Diabetologia. 2012;55(11):2920\u20132928. doi:10.1007/s00125-012-2685-z", "ArticleIdList": ["10.1007/s00125-012-2685-z", "PMC3464379", "22935960"]}, {"Citation": "Pieper GM, Siebeneich W. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol. 1998;32(1):101\u2013105. doi:10.1097/00005344-199807000-00016", "ArticleIdList": ["10.1097/00005344-199807000-00016", "9676728"]}, {"Citation": "Sahin G, Yalcin AU, Akcar N. Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients. Blood Purif. 2007;25(4):309\u2013315. doi:10.1159/000106103", "ArticleIdList": ["10.1159/000106103", "17643057"]}, {"Citation": "Martinez de Lizarrondo S, Gakuba C, Herbig BA, et al. Potent thrombolytic effect of N-acetylcysteine on arterial thrombi. Circulation. 2017;136(7):646\u2013660. doi:10.1161/CIRCULATIONAHA.117.027290", "ArticleIdList": ["10.1161/CIRCULATIONAHA.117.027290", "PMC5560034", "28487393"]}, {"Citation": "Chen J, Reheman A, Gushiken FC, et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest. 2011;121(2):593\u2013603. doi:10.1172/JCI41062", "ArticleIdList": ["10.1172/JCI41062", "PMC3026714", "21266777"]}, {"Citation": "Samuni Y, Goldstein S, Dean OM, Berk M. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta. 2013;1830(8):4117\u20134129. doi:10.1016/j.bbagen.2013.04.016", "ArticleIdList": ["10.1016/j.bbagen.2013.04.016", "23618697"]}, {"Citation": "Emet S, Memi\u015f D, Pamuk\u00e7u Z. The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis. Crit Care. 2004;8(4):R172. doi:10.1186/cc2866", "ArticleIdList": ["10.1186/cc2866", "PMC522835", "15312215"]}, {"Citation": "Nascimento MM, Suliman ME, Silva M, et al. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Perit Dial Int. 2010;30(3):336\u2013342. doi:10.3747/pdi.2009.00073", "ArticleIdList": ["10.3747/pdi.2009.00073", "20190028"]}, {"Citation": "Chen G, Shi J, Hu Z, Hang C. Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine. Mediators Inflamm. 2008;2008:1\u20138. doi:10.1155/2008/716458", "ArticleIdList": ["10.1155/2008/716458", "PMC2375967", "18483565"]}, {"Citation": "Frijns C, Kappelle L. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke. 2002;33(8):2115\u20132122. doi:10.1161/01.STR.0000021902.33129.69", "ArticleIdList": ["10.1161/01.STR.0000021902.33129.69", "12154274"]}, {"Citation": "Spiecker M, Darius H, Kaboth K, H\u00fcbner F, Liao JK. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol. 1998;63(6):732\u2013739. doi:10.1002/jlb.63.6.732", "ArticleIdList": ["10.1002/jlb.63.6.732", "9620666"]}, {"Citation": "Radomska-Lesniewska D, Sadowska A, Van Overveld F, Demkow U, Zielinski J, De Backer W. Influence of** N**-acetylcysteine on ICAM-1 expression and il-8 release from endothelial and epithelial cells. J Physiol Pharmacol. 2007;57(S4):325\u2013334.", "ArticleIdList": ["17072061"]}, {"Citation": "Fries GR, Kapczinski F. N-acetylcysteine as a mitochondrial enhancer: a new class of psychoactive drugs? Braz J Psychiatry. 2011;33(4):321\u2013322. doi:10.1590/S1516-44462011000400003", "ArticleIdList": ["10.1590/S1516-44462011000400003", "22189921"]}, {"Citation": "Basha RH, Priscilla DH. An in vivo and in vitro study on the protective effects of N-acetylcysteine on mitochondrial dysfunction in isoproterenol treated myocardial infarcted rats. Exp Toxicol Pathol. 2013;65(1\u20132):7\u201314. doi:10.1016/j.etp.2011.05.002", "ArticleIdList": ["10.1016/j.etp.2011.05.002", "21641783"]}, {"Citation": "Xiong Y, Peterson P, Lee C. Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats. J Neurotrauma. 1999;16(11):1067\u20131082. doi:10.1089/neu.1999.16.1067", "ArticleIdList": ["10.1089/neu.1999.16.1067", "10595823"]}, {"Citation": "Cocco T, Sgobbo P, Clemente M, et al. Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine. Free Radic Biol Med. 2005;38(6):796\u2013805. doi:10.1016/j.freeradbiomed.2004.11.034", "ArticleIdList": ["10.1016/j.freeradbiomed.2004.11.034", "15721990"]}, {"Citation": "Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2014;115:157\u2013188. doi:10.1016/j.pneurobio.2013.11.006", "ArticleIdList": ["10.1016/j.pneurobio.2013.11.006", "24361499"]}, {"Citation": "Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011;36(2):78. doi:10.1503/jpn.100057", "ArticleIdList": ["10.1503/jpn.100057", "PMC3044191", "21118657"]}, {"Citation": "Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK. Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci. 2005;25(27):6389\u20136393. doi:10.1523/JNEUROSCI.1007-05.2005", "ArticleIdList": ["10.1523/JNEUROSCI.1007-05.2005", "PMC1413952", "16000629"]}, {"Citation": "Lakhan SE, Kirchgessner A, Tepper D, Aidan L. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol. 2013;4:32. doi:10.3389/fneur.2013.00032", "ArticleIdList": ["10.3389/fneur.2013.00032", "PMC3615191", "23565108"]}, {"Citation": "Yu F, Kamada H, Niizuma K, Endo H, Chan PH. Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma. 2008;25(3):184\u2013195. doi:10.1089/neu.2007.0438", "ArticleIdList": ["10.1089/neu.2007.0438", "PMC2365489", "18352832"]}, {"Citation": "Ramaesh T, Ramaesh K, Riley S, West J, Dhillon B. Effects of N-acetylcysteine on matrix metalloproteinase-9 secretion and cell migration of human corneal epithelial cells. Eye. 2012;26(8):1138\u20131144. doi:10.1038/eye.2012.135", "ArticleIdList": ["10.1038/eye.2012.135", "PMC3420048", "22766540"]}, {"Citation": "Voronkina I, Vakhromova E, Kirpichnikova K, Smagina L, Gamaley I. Matrix metalloproteinase activity in transformed cells exposed to an antioxidant. Cell Tissue Biol. 2015;9(1):16\u201323. doi:10.1134/S1990519X15010113", "ArticleIdList": ["10.1134/S1990519X15010113"]}, {"Citation": "Heard KJ. Acetylcysteine for acetaminophen poisoning. New Engl J Med. 2008;359(3):285\u2013292. doi:10.1056/NEJMct0708278", "ArticleIdList": ["10.1056/NEJMct0708278", "PMC2637612", "18635433"]}, {"Citation": "De Rosa S, Zaretsky M, Dubs J, et al. N\u2010acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest. 2000;30(10):915\u2013929. doi:10.1046/j.1365-2362.2000.00736.x", "ArticleIdList": ["10.1046/j.1365-2362.2000.00736.x", "11029607"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "8"}, {"Year": "2020", "Month": "5", "Day": "1"}, {"Year": "2020", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "18", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "5", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["32547030", "PMC7244239", "10.2147/NDT.S241497", "241497"]}}]}